Allied Minds creates funding vehicle for BMS JV

The newly formed ABLS Capital subsidiary of Allied Minds plc (LSE:ALM) has secured commitments of up to $80 million to fund programs in Allied Minds' joint venture with Bristol-Myers Squibb Co. (NYSE:BMY). The funds will support lead

Read the full 370 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE